2 Miss. Code. R. 1-3-11-01-118.06
Spot or localized area treatment is allowed for all construction types, provided the purchaser requests in writing to the licensee this type of treatment prior to the termiticide application. A copy of the customer's request shall be maintained in the pest control operator's customer file. The licensee shall write on the face of the contract "Spot Treatment" and clearly define area treated on the graph. The contract must guarantee the area treated for one year. The monthly structural report shall state "Spot Treatment".
Post Construction Structural Treatment-
Fipronil EP/LI treatment may be performed on existing structures according to the product label instructions. Subsections 118.02(1), (2), (3), (5) and/or 118.03 (4) of these regulations must be followed. The face of the contract shall specify "trade name of product Exterior Perimeter/Localized Interior" and the areas treated and the application methods used shall be clearly defined on the graph and application records. Known termite activity at time of treatment must be clearly noted on the graph. The monthly structural report shall state "trade name of product EP/LI." Proof of licensee training in the use of the approved Fipronil labeled for EP/LI, as approved by the Bureau, is required prior to the initial use of the approved Fipronil labeled as an EP/LI treatment.
Post Construction Structural Treatment-
Imidacloprid Exterior Perimeter/Interior Spot Treatment may be performed on existing slab type construction according to the Imidacloprid label instructions. For pier-type crawl space construction, treat according to label instructions; except all piers and plumbing and utility penetrations entering soil in accessible crawl spaces must be treated by trenching and rodding into the trench or trenching, even if there is no termite infestation. Subsections 118.02(1), (2), (3), (5) and/or 118.03 (4) of these regulations must be followed. The face of the contract shall specify "Imidacloprid Exterior Perimeter/Interior Spot Treatment" and the areas treated and the application methods used shall be clearly defined on the graph and application records. Known termite activity at time of treatment must be clearly noted on the graph. The monthly structural report shall state "trade name of product EP/IST." Proof of licensee training in the use of Imidacloprid EP/IST, as approved by the Bureau, is required prior to the initial use of Imidacloprid as an EP/IST application.
2 Miss. Code. R. 1-3-11-01-118.06